GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medlive Technology Co Ltd (HKSE:02192) » Definitions » Beneish M-Score

Medlive Technology Co (HKSE:02192) Beneish M-Score : -2.09 (As of May. 16, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Medlive Technology Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.09 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Medlive Technology Co's Beneish M-Score or its related term are showing as below:

HKSE:02192' s Beneish M-Score Range Over the Past 10 Years
Min: -3.11   Med: -1.91   Max: -1.59
Current: -2.09

During the past 6 years, the highest Beneish M-Score of Medlive Technology Co was -1.59. The lowest was -3.11. And the median was -1.91.


Medlive Technology Co Beneish M-Score Historical Data

The historical data trend for Medlive Technology Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlive Technology Co Beneish M-Score Chart

Medlive Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial - -3.11 -1.59 -1.72 -2.09

Medlive Technology Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.59 - -1.72 - -2.09

Competitive Comparison of Medlive Technology Co's Beneish M-Score

For the Medical Distribution subindustry, Medlive Technology Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medlive Technology Co's Beneish M-Score Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medlive Technology Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Medlive Technology Co's Beneish M-Score falls into.



Medlive Technology Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Medlive Technology Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9531+0.528 * 1.1104+0.404 * 1.2313+0.892 * 1.2849+0.115 * 0.8323
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8928+4.679 * 0.028696-0.327 * 1.3101
=-2.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was HK$176.2 Mil.
Revenue was HK$450.6 Mil.
Gross Profit was HK$274.9 Mil.
Total Current Assets was HK$5,001.4 Mil.
Total Assets was HK$5,352.8 Mil.
Property, Plant and Equipment(Net PPE) was HK$12.1 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$10.3 Mil.
Selling, General, & Admin. Expense(SGA) was HK$193.9 Mil.
Total Current Liabilities was HK$207.6 Mil.
Long-Term Debt & Capital Lease Obligation was HK$4.0 Mil.
Net Income was HK$265.0 Mil.
Gross Profit was HK$0.0 Mil.
Cash Flow from Operations was HK$111.4 Mil.
Total Receivables was HK$143.9 Mil.
Revenue was HK$350.7 Mil.
Gross Profit was HK$237.6 Mil.
Total Current Assets was HK$4,859.6 Mil.
Total Assets was HK$5,140.5 Mil.
Property, Plant and Equipment(Net PPE) was HK$16.3 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$10.0 Mil.
Selling, General, & Admin. Expense(SGA) was HK$169.0 Mil.
Total Current Liabilities was HK$148.2 Mil.
Long-Term Debt & Capital Lease Obligation was HK$6.8 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(176.243 / 450.641) / (143.909 / 350.709)
=0.391094 / 0.410337
=0.9531

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(237.571 / 350.709) / (274.905 / 450.641)
=0.677402 / 0.610031
=1.1104

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (5001.4 + 12.114) / 5352.753) / (1 - (4859.638 + 16.273) / 5140.494)
=0.063377 / 0.05147
=1.2313

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=450.641 / 350.709
=1.2849

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(10.036 / (10.036 + 16.273)) / (10.25 / (10.25 + 12.114))
=0.381466 / 0.458326
=0.8323

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(193.882 / 450.641) / (169.006 / 350.709)
=0.430236 / 0.481898
=0.8928

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((3.985 + 207.569) / 5352.753) / ((6.841 + 148.239) / 5140.494)
=0.039522 / 0.030168
=1.3101

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(265.024 - 0 - 111.419) / 5352.753
=0.028696

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Medlive Technology Co has a M-score of -2.09 suggests that the company is unlikely to be a manipulator.


Medlive Technology Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Medlive Technology Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Medlive Technology Co (HKSE:02192) Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Baijialou Chaoyang North Road, E1 Red Manor International Bonded Innovation Park, Chaoyang District, Beijing, CHN
Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians on the platform who drive procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan's leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.

Medlive Technology Co (HKSE:02192) Headlines

No Headlines